Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 01 10 2020
accepted: 19 11 2020
entrez: 3 12 2020
pubmed: 4 12 2020
medline: 19 12 2020
Statut: epublish

Résumé

Rapid identification of patients with high suspicion of COVID-19 will become a challenge with the co-circulation of multiple respiratory viruses (RVs). We have identified clinical or biological characteristics to help distinguish SARS-CoV-2 from other RVs. We used a prospective cohort including all consecutive patients admitted through the emergency department's (ED) and presenting respiratory symptoms from November 2019 to April 2020. Patients were tested for RV using multiplex polymerase chain reaction (mPCR) and SARS-CoV-2 RT-PCR. 203/508 patients were positive for an RV during the non-SARS-CoV-2 epidemic period (November to February), and 268/596 patients were SARS-CoV-2 positive during the SARS-CoV-2 epidemic (March to April). Younger age, male gender, fever, absence of expectoration and absence of chronic lung disease were statistically associated with SARS-CoV-2 detection. Combining these variables allowed for the distinguishing of SARS-CoV-2 infections with 83, 65, 75 and 76% sensitivity, specificity, PPV and NPV, respectively. Patients' characteristics associated with a positive PCR are common between SARS-CoV-2 and other RVs, but a simple discrimination of strong SARS-CoV-2 suspicion with a limited set of clinical features seems possible. Such scoring could be useful but has to be prospectively evaluated and will not eliminate the need for rapid PCR assays.

Sections du résumé

BACKGROUND
Rapid identification of patients with high suspicion of COVID-19 will become a challenge with the co-circulation of multiple respiratory viruses (RVs). We have identified clinical or biological characteristics to help distinguish SARS-CoV-2 from other RVs.
METHODS
We used a prospective cohort including all consecutive patients admitted through the emergency department's (ED) and presenting respiratory symptoms from November 2019 to April 2020. Patients were tested for RV using multiplex polymerase chain reaction (mPCR) and SARS-CoV-2 RT-PCR.
RESULTS
203/508 patients were positive for an RV during the non-SARS-CoV-2 epidemic period (November to February), and 268/596 patients were SARS-CoV-2 positive during the SARS-CoV-2 epidemic (March to April). Younger age, male gender, fever, absence of expectoration and absence of chronic lung disease were statistically associated with SARS-CoV-2 detection. Combining these variables allowed for the distinguishing of SARS-CoV-2 infections with 83, 65, 75 and 76% sensitivity, specificity, PPV and NPV, respectively.
CONCLUSION
Patients' characteristics associated with a positive PCR are common between SARS-CoV-2 and other RVs, but a simple discrimination of strong SARS-CoV-2 suspicion with a limited set of clinical features seems possible. Such scoring could be useful but has to be prospectively evaluated and will not eliminate the need for rapid PCR assays.

Identifiants

pubmed: 33270790
doi: 10.1371/journal.pone.0243261
pii: PONE-D-20-30439
pmc: PMC7714208
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243261

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

DB and BV declare having received past personal fees and grant from Qiagen. All the others declare having no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Microbes Infect. 2020 Oct;22(9):481-488
pubmed: 32561409
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
JAMA. 2020 Oct 6;324(13):1342-1343
pubmed: 32797145
J Clin Virol. 2020 Aug;129:104470
pubmed: 32480215
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
J Clin Microbiol. 2018 Jan 24;56(2):
pubmed: 29212701
Biomark Med. 2020 Jun;14(9):713-716
pubmed: 32426991
Clin Microbiol Infect. 2019 Sep;25(9):1147-1153
pubmed: 30703528
JAMA. 2020 May 26;323(20):2085-2086
pubmed: 32293646
Clin Microbiol Infect. 2017 Apr;23(4):253-259
pubmed: 27903461
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
Lancet Glob Health. 2019 Aug;7(8):e1031-e1045
pubmed: 31303294
J Clin Virol. 2020 Aug;129:104520
pubmed: 32652476
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29593057
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32341142

Auteurs

Donia Bouzid (D)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Jimmy Mullaert (J)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Department of Epidemiology, Biostatistics and Clinical Research, Bichat-Claude Bernard University Hospital, Paris, France.

Quentin Le Hingrat (Q)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Odile Laurent (O)

AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Xavier Duval (X)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Xavier Lescure (X)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Infectious Diseases Department, Bichat-Claude Bernard University Hospital, Paris, France.

Jean-François Timsit (JF)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard University Hospital, Paris, France.

Diane Descamps (D)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Philippe Montravers (P)

AP-HP Nord, Department of Anesthesiology and Critical Care Medicine, Bichat-Claude Bernard University Hospital, Paris, France.

Christophe Choquet (C)

AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Jean-Christophe Lucet (JC)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Infection Control Unit, Bichat-Claude Bernard University Hospital, Paris, France.

Enrique Casalino (E)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.

Benoit Visseaux (B)

INSERM, IAME, Université de Paris, Paris, France.
AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH